Abstract.
Ankylosing spondylitis is an inflammatory disorder affecting the axial skeleton and periphery. Symptoms can often be debilitating. Current therapy for the disease include physical therapy, non-steroidal anti-inflammatory drugs (NSAIDS, anti-rheumatic disease modifying drugs (DMARDS), and the newly developed biologic agents targeting tumor necrosis factor alpha (TNF-α). This paper will provide a comprehensive review of these treatments which focusing on evidence based medicine for the daily clinical practice of rheumatology.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 31 December 2002 / Accepted: 15 January 2003
Correspondence to J.C. Davis Jr.
Rights and permissions
About this article
Cite this article
Scalapino, K., Davis Jr., J. The treatment of ankylosing spondylitis. Clin Exp Med 2, 159–165 (2003). https://doi.org/10.1007/s102380300000
Issue Date:
DOI: https://doi.org/10.1007/s102380300000